TGFB1 and central nervous system cancer: Results of a PET imaging study with TGFβ-specific monoclonal GC1008, as a carrier of radionuclide-labeled tracer, showed that [89Zr]-GC1008 could well penetrate recurrent high-grade gliomas (14).